Study to restore thymus function and improve insulin control
Part of Immune system & allergy clinical trials.
This Phase 2 study tests a treatment aimed at improving immune system function and reducing insulin problems over 12 months. You may be able to join if you’re between 40 and 80 and don’t have certain diabetes, hormonal, heart, or immune conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 40 to 80 years old and can join for the full 12 months
- You can clearly agree to take part (informed consent)
- You do not have cancer now or a strong personal/family cancer risk
- You do not have conditions linked to growth hormone problems (or recent growth hormone use in the last 5 years)
- You do not have Type 1 or long-standing pre-existing Type 2 diabetes, and you’re not on strict fasting or ketogenic diets for the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug that may help preserve the body's ability to make insulin in people with type 1 diabetes. It aims to slow the progression of the disease and reduce the need for insulin injections.
This trial tests a drug that may help your body use insulin better and improve how your cells produce energy. It might lead to better blood sugar control and less insulin needed.
This trial tests a medicine called anti-thymocyte globulin (h-ATG) to see if it can help people with type 1 diabetes keep making some of their own insulin. It may slow the loss of insulin-making cells and help manage blood sugar.
This trial tests two FDA-approved drugs, rapamycin and everolimus, to see if they can improve immune function in healthy older adults. You may join if you are generally healthy, live independently, and are between 65 and 90 years old.
This study tests an experimental medicine called RGB-5088 for people with type 2 diabetes who are already using insulin. The goal is to see if it can safely improve blood sugar control when added to your current diabetes management.
This Phase 1 study tests a new immune-system strategy around islet transplantation (or donor bone marrow therapy) to improve control of type 1 diabetes and reduce dangerous low blood sugar. It mainly aims to see if the approach is safe and helpful in people with long-standing, difficult-to-manage diabetes.
Hear when a new Epigenetic Aging trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.